Metsä Board Oyj (METSA.HE)

Negative gross profit growth while UPM.HE is at 1.38%. Joel Greenblatt would examine cost competitiveness or demand decline.

Negative EBIT growth while UPM.HE is at 28.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.

Negative operating income growth while UPM.HE is at 28.08%. Joel Greenblatt would press for urgent turnaround measures.

Negative net income growth while UPM.HE stands at 21.05%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.

Negative EPS growth while UPM.HE is at 18.18%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.

Negative diluted EPS growth while UPM.HE is at 18.18%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.

Share count expansion well above UPM.HE's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.

Diluted share count expanding well above UPM.HE's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.

Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.

Negative FCF growth while UPM.HE is at 1280.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.

Negative 10Y revenue/share CAGR while UPM.HE stands at 0.61%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.

Negative 5Y CAGR while UPM.HE stands at 2.21%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Negative 3Y CAGR while UPM.HE stands at 3.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.

Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.

Negative 5Y OCF/share CAGR while UPM.HE is at 60.89%. Joel Greenblatt would question the firm’s operational model or cost structure.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Below 50% of UPM.HE's 257.97%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.

Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

Negative 3Y equity/share growth while UPM.HE is at 5.31%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.

No Data available this quarter, please select a different quarter.

No Data available this quarter, please select a different quarter.

Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.

Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.

Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.

We have a declining book value while UPM.HE shows 0.61%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.

Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.

We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.